Literature DB >> 15302427

"Opioid creep" is real and may be the cause of "fluid creep".

Stephen R Sullivan1, Jeffrey B Friedrich, Loren H Engrav, Kurt A Round, David M Heimbach, Susan R Heckbert, Gretchen J Carrougher, Dennis C Lezotte, Shelley A Wiechman, Shari Honari, Matthew B Klein, Nicole S Gibran.   

Abstract

Recent studies have shown that burn patients receive larger volumes of fluids than predicted by the Baxter formula and the reason for this is unclear. One potential reason is that increased analgesics are used which could blunt the response to fluid resuscitation. The purpose of this study was to compare the administration of opioid agonists in patients treated at a single burn center in the 1970s and in the year 2000. We performed a retrospective chart review comparing two matched cohorts. Group I consisted of 11 patients admitted between 1975 and 1978. Group II consisted of 11 patients admitted in 2000 matched for age, sex and %TBSA. Patients in Group II received a significantly higher mean opioid equivalent than those in Group I (26.5 +/- 12.3 versus 3.9 +/- 2.2 in the first 24h, P < 0.001). In addition, in Group II, a larger variety and combination of opioid agonists were used. This review demonstrates a significant increase from the 1970s to 2000 in the type, dose prescribed and dose delivered of opioid agonists. Along with "fluid creep", we have also increased our use of opioid agonists or "opioid creep". Higher doses of opioid agonists may have hemodynamic consequences, which may contribute to the increased fluid volumes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302427     DOI: 10.1016/j.burns.2004.03.002

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  19 in total

1.  Burn resuscitation: is it straightforward or a challenge?

Authors:  S Hayek; A Ibrahim; G Abu Sittah; B Atiyeh
Journal:  Ann Burns Fire Disasters       Date:  2011-03-31

2.  [When is enough enough or even too much?].

Authors:  S Rex
Journal:  Anaesthesist       Date:  2011-04       Impact factor: 1.041

Review 3.  [Estimation of substitution volume after burn trauma. Systematic review of published formulae].

Authors:  O Spelten; W A Wetsch; S Braunecker; H Genzwürker; J Hinkelbein
Journal:  Anaesthesist       Date:  2011-03-31       Impact factor: 1.041

4.  Management of pain, anxiety, agitation and delirium in burn patients: a survey of clinical practice and a review of the current literature.

Authors:  N Depetris; S Raineri; O Pantet; A Lavrentieva
Journal:  Ann Burns Fire Disasters       Date:  2018-06-30

5.  Acute burn resuscitation and fluid creep: it is time for colloid rehabilitation.

Authors:  B S Atiyeh; S A Dibo; A E Ibrahim; E R Zgheib
Journal:  Ann Burns Fire Disasters       Date:  2012-06-30

6.  Analgesia, sedation and arousal status in burn patients: the gap between recommendations and current practices.

Authors:  A Lavrentieva; N Depetris; I Rodini
Journal:  Ann Burns Fire Disasters       Date:  2017-06-30

7.  New management strategy for fluid resuscitation: quantifying volume in the first 48 hours after burn injury.

Authors:  Katrina B Mitchell; Elie Khalil; Ann Brennan; Huibo Shao; Angela Rabbitts; Nicole E Leahy; Roger W Yurt; James J Gallagher
Journal:  J Burn Care Res       Date:  2013 Jan-Feb       Impact factor: 1.845

Review 8.  Acute and perioperative care of the burn-injured patient.

Authors:  Edward A Bittner; Erik Shank; Lee Woodson; J A Jeevendra Martyn
Journal:  Anesthesiology       Date:  2015-02       Impact factor: 7.892

9.  The contribution of opiate analgesics to the development of infectious complications in trauma patients.

Authors:  Richard F Oppeltz; Travis L Holloway; Cody J Covington; Martin G Schwacha
Journal:  Int J Burns Trauma       Date:  2015-08-01

Review 10.  Bench-to-bedside review: Burn-induced cerebral inflammation--a neglected entity?

Authors:  Michael A Flierl; Philip F Stahel; Basel M Touban; Kathryn M Beauchamp; Steven J Morgan; Wade R Smith; Kyros R Ipaktchi
Journal:  Crit Care       Date:  2009-06-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.